(Información remitida por la empresa firmante)
VADUZ, Liechtenstein, May 5, 2023 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the first quarter 2023 at 15:00 CET on May 12. The interim report for the first quarter will be published at 8:00 a.m. CET on the same day.
The presentation will be in English via an audiocast with teleconference:
Conference call dial-in:
- Sweden: +46 8 505 163 86
- United Kingdom: +44 20 319 84884
- United States: +1-412-317-6300
Pin code: 9354290#
Webcast:
Speakers:
- CEO Peter Forsell
- CFO Andreas hrnberg
- Chief Corporate Affairs Officer Nicole Pehrsson
For further information, please contact:
Nicole Pehrsson, Investor RelationsTelephone (CH): +41 (0)79 335 09 49nicole.pehrsson@implantica.com
Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.
The company's Certified Adviser is FNCA Sweden AB, info@fnca.se
The information was sent for publication, through the agency of the contact person set out above, on May 5, 2023 at 01:30 p.m. CET.
About Implantica
Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica's lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.
The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/implantica-presents-the-first-quarter-2023-on-may-12-at-1500-cet-301817171.html